Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment.

Jones D, Woyach JA, Zhao W, Caruthers S, Tu H, Coleman J, Byrd JC, Johnson AJ, Lozanski G.

Leukemia. 2017 Jul;31(7):1645-1647. doi: 10.1038/leu.2017.110. Epub 2017 Apr 3. No abstract available.

PMID:
28366935
2.

Recent Advances in 19Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions.

Schmieder AH, Caruthers SD, Keupp J, Wickline SA, Lanza GM.

Engineering (Beijing). 2015 Dec;1(4):475-489. Epub 2016 Mar 16.

3.

High-quality t2-weighted 4-dimensional magnetic resonance imaging for radiation therapy applications.

Du D, Caruthers SD, Glide-Hurst C, Low DA, Li HH, Mutic S, Hu Y.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):430-7. doi: 10.1016/j.ijrobp.2015.01.035. Epub 2015 Mar 30.

4.

Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers.

Wang K, Pan D, Schmieder AH, Senpan A, Hourcade DE, Pham CT, Mitchell LM, Caruthers SD, Cui G, Wickline SA, Shen B, Lanza GM.

Nanomedicine. 2015 Apr;11(3):601-9. doi: 10.1016/j.nano.2014.12.009. Epub 2015 Jan 31.

5.

Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits.

Wang K, Pan D, Schmieder AH, Senpan A, Caruthers SD, Cui G, Allen JS, Zhang H, Shen B, Lanza GM.

Nanomedicine. 2015 Apr;11(3):569-78. doi: 10.1016/j.nano.2014.12.008. Epub 2015 Jan 31.

6.

Improved quantitative (19) F MR molecular imaging with flip angle calibration and B1 -mapping compensation.

Goette MJ, Lanza GM, Caruthers SD, Wickline SA.

J Magn Reson Imaging. 2015 Aug;42(2):488-94. doi: 10.1002/jmri.24812. Epub 2014 Nov 25.

7.

Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces.

Myerson JW, He L, Allen JS, Williams T, Lanza G, Tollefsen D, Caruthers S, Wickline S.

Nanotechnology. 2014 Oct 3;25(39):395101. doi: 10.1088/0957-4484/25/39/395101. Epub 2014 Sep 9.

8.

Balanced UTE-SSFP for 19F MR imaging of complex spectra.

Goette MJ, Keupp J, Rahmer J, Lanza GM, Wickline SA, Caruthers SD.

Magn Reson Med. 2015 Aug;74(2):537-43. doi: 10.1002/mrm.25437. Epub 2014 Aug 27.

9.

Angiogenesis and airway reactivity in asthmatic Brown Norway rats.

Wagner EM, Jenkins J, Schmieder A, Eldridge L, Zhang Q, Moldobaeva A, Zhang H, Allen JS, Yang X, Mitzner W, Keupp J, Caruthers SD, Wickline SA, Lanza GM.

Angiogenesis. 2015 Jan;18(1):1-11. doi: 10.1007/s10456-014-9441-6. Epub 2014 Aug 23.

10.

E-wave generated intraventricular diastolic vortex to L-wave relation: model-based prediction with in vivo validation.

Ghosh E, Caruthers SD, Kovács SJ.

J Appl Physiol (1985). 2014 Aug 1;117(3):316-24. doi: 10.1152/japplphysiol.00215.2014. Epub 2014 Jun 5.

11.

MR cholangiography demonstrates unsuspected rapid biliary clearance of nanoparticles in rodents: implications for clinical translation.

Bulte JW, Schmieder AH, Keupp J, Caruthers SD, Wickline SA, Lanza GM.

Nanomedicine. 2014 Oct;10(7):1385-8. doi: 10.1016/j.nano.2014.05.001. Epub 2014 May 14.

12.

Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles.

Pan D, Schmieder AH, Wang K, Yang X, Senpan A, Cui G, Killgore K, Kim B, Allen JS, Zhang H, Caruthers SD, Shen B, Wickline SA, Lanza GM.

Theranostics. 2014 Mar 11;4(6):565-78. doi: 10.7150/thno.7581. eCollection 2014.

13.

Bicuspid Pulmonic Valve and Pulmonary Artery Aneurysm.

Jamis-Dow CA, Barbier GH, Watkins MP, Lanza GM, Caruthers SD, Wickline SA.

Cardiol Res. 2014 Apr;5(2):83-84.

14.

Assessing intrarenal nonperfusion and vascular leakage in acute kidney injury with multinuclear (1) H/(19) F MRI and perfluorocarbon nanoparticles.

Hu L, Chen J, Yang X, Senpan A, Allen JS, Yanaba N, Caruthers SD, Lanza GM, Hammerman MR, Wickline SA.

Magn Reson Med. 2014 Jun;71(6):2186-96. doi: 10.1002/mrm.24851. Epub 2013 Aug 8.

15.

Characterization of early neovascular response to acute lung ischemia using simultaneous (19)F/ (1)H MR molecular imaging.

Schmieder AH, Wang K, Zhang H, Senpan A, Pan D, Keupp J, Caruthers SD, Wickline SA, Shen B, Wagner EM, Lanza GM.

Angiogenesis. 2014 Jan;17(1):51-60. doi: 10.1007/s10456-013-9377-2. Epub 2013 Aug 6.

16.

Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.

Schmieder AH, Winter PM, Williams TA, Allen JS, Hu G, Zhang H, Caruthers SD, Wickline SA, Lanza GM.

Radiology. 2013 Aug;268(2):470-80. doi: 10.1148/radiol.13120789. Epub 2013 Jun 14.

17.

Respiratory amplitude guided 4-dimensional magnetic resonance imaging.

Hu Y, Caruthers SD, Low DA, Parikh PJ, Mutic S.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):198-204. doi: 10.1016/j.ijrobp.2012.12.014. Epub 2013 Feb 13.

18.

Could contrast-enhanced cardiovascular MRI potentially be used to screen pediatric cardiac transplant patients for transplant coronary artery disease?

Caruthers SD, Madani MH, Wickline SA, Canter CE.

Expert Rev Cardiovasc Ther. 2012 Dec;10(12):1459-61. doi: 10.1586/erc.12.149. No abstract available.

PMID:
23253269
19.

Cardiomyocyte architectural plasticity in fetal, neonatal, and adult pig hearts delineated with diffusion tensor MRI.

Zhang L, Allen J, Hu L, Caruthers SD, Wickline SA, Chen J.

Am J Physiol Heart Circ Physiol. 2013 Jan 15;304(2):H246-52. doi: 10.1152/ajpheart.00129.2012. Epub 2012 Nov 16.

20.

Rapid quantification of oxygen tension in blood flow with a fluorine nanoparticle reporter and a novel blood flow-enhanced-saturation-recovery sequence.

Hu L, Chen J, Yang X, Caruthers SD, Lanza GM, Wickline SA.

Magn Reson Med. 2013 Jul;70(1):176-83. doi: 10.1002/mrm.24436. Epub 2012 Aug 22.

21.

Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts.

Cheng YJ, Lang D, Caruthers SD, Efimov IR, Chen J, Wickline SA.

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H559-68. doi: 10.1152/ajpheart.00321.2012. Epub 2012 Jul 9.

22.

WE-G-213CD-04: A Triggering System to Guide 4DMRI Image Acquisition.

Hu Y, Caruthers S, Low D, Parikh P, Mutic S.

Med Phys. 2012 Jun;39(6Part28):3971. doi: 10.1118/1.4736205.

PMID:
28519607
23.

Quantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticles.

Cai K, Kiefer GE, Caruthers SD, Wickline SA, Lanza GM, Winter PM.

NMR Biomed. 2012 Feb;25(2):279-85. doi: 10.1002/nbm.1746. Epub 2011 Jul 12.

24.

A generalized strategy for designing (19)F/(1)H dual-frequency MRI coil for small animal imaging at 4.7 Tesla.

Hu L, Hockett FD, Chen J, Zhang L, Caruthers SD, Lanza GM, Wickline SA.

J Magn Reson Imaging. 2011 Jul;34(1):245-52. doi: 10.1002/jmri.22516.

PMID:
21698714
25.

Synthesis of NanoQ, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus.

Pan D, Caruthers SD, Senpan A, Yalaz C, Stacy AJ, Hu G, Marsh JN, Gaffney PJ, Wickline SA, Lanza GM.

J Am Chem Soc. 2011 Jun 22;133(24):9168-71. doi: 10.1021/ja201918u. Epub 2011 May 26.

26.

A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke.

Marsh JN, Hu G, Scott MJ, Zhang H, Goette MJ, Gaffney PJ, Caruthers SD, Wickline SA, Abendschein D, Lanza GM.

Nanomedicine (Lond). 2011 Jun;6(4):605-15. doi: 10.2217/nnm.11.21. Epub 2011 Apr 20.

27.

Simultaneous dual-nuclei imaging for motion corrected detection and quantification of 19F imaging agents.

Keupp J, Rahmer J, Grässlin I, Mazurkewitz PC, Schaeffter T, Lanza GM, Wickline SA, Caruthers SD.

Magn Reson Med. 2011 Oct;66(4):1116-22. doi: 10.1002/mrm.22877. Epub 2011 Mar 9.

28.

Computed tomography in color: NanoK-enhanced spectral CT molecular imaging.

Pan D, Roessl E, Schlomka JP, Caruthers SD, Senpan A, Scott MJ, Allen JS, Zhang H, Hu G, Gaffney PJ, Choi ET, Rasche V, Wickline SA, Proksa R, Lanza GM.

Angew Chem Int Ed Engl. 2010 Dec 10;49(50):9635-9. doi: 10.1002/anie.201005657. No abstract available.

29.

Quantitative cardiovascular magnetic resonance for molecular imaging.

Winter PM, Caruthers SD, Lanza GM, Wickline SA.

J Cardiovasc Magn Reson. 2010 Nov 3;12:62. doi: 10.1186/1532-429X-12-62. Review.

30.

Rationale for a nanomedicine approach to thrombolytic therapy.

Lanza GM, Marsh JN, Hu G, Scott MJ, Schmieder AH, Caruthers SD, Pan D, Wickline SA.

Stroke. 2010 Oct;41(10 Suppl):S42-4. doi: 10.1161/STROKEAHA.110.598656. Review. No abstract available.

31.

Revisiting an old friend: manganese-based MRI contrast agents.

Pan D, Caruthers SD, Senpan A, Schmieder AH, Wickline SA, Lanza GM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):162-73. doi: 10.1002/wnan.116. Epub 2010 Sep 21. Review.

32.

MR molecular imaging of aortic angiogenesis.

Cai K, Caruthers SD, Huang W, Williams TA, Zhang H, Wickline SA, Lanza GM, Winter PM.

JACC Cardiovasc Imaging. 2010 Aug;3(8):824-32. doi: 10.1016/j.jcmg.2010.03.012.

33.

Simultaneous dual frequency 1H and 19F open coil imaging of arthritic rabbit knee at 3T.

Hockett FD, Wallace KD, Schmieder AH, Caruthers SD, Pham CT, Wickline SA, Lanza GM.

IEEE Trans Med Imaging. 2011 Jan;30(1):22-7. doi: 10.1109/TMI.2010.2056689. Epub 2010 Aug 9.

34.

Molecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles.

Winter PM, Caruthers SD, Allen JS, Cai K, Williams TA, Lanza GM, Wickline SA.

Magn Reson Med. 2010 Aug;64(2):369-76. doi: 10.1002/mrm.22447.

35.

Angiogenesis imaging with vascular-constrained particles: the why and how.

Lanza GM, Caruthers SD, Winter PM, Hughes MS, Schmieder AH, Hu G, Wickline SA.

Eur J Nucl Med Mol Imaging. 2010 Aug;37 Suppl 1:S114-26. doi: 10.1007/s00259-010-1502-5. Review.

PMID:
20617434
36.

Assessment of tumor angiogenesis: dynamic contrast-enhanced MRI with paramagnetic nanoparticles compared with Gd-DTPA in a rabbit Vx-2 tumor model.

Kassner A, Thornhill RE, Liu F, Winter PM, Caruthers SD, Wickline SA, Lanza GM.

Contrast Media Mol Imaging. 2010 May-Jun;5(3):155-61. doi: 10.1002/cmmi.380.

PMID:
20586031
37.

MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma model.

Boles KS, Schmieder AH, Koch AW, Carano RA, Wu Y, Caruthers SD, Tong RK, Stawicki S, Hu G, Scott MJ, Zhang H, Reynolds BA, Wickline SA, Lanza GM.

FASEB J. 2010 Nov;24(11):4262-70. doi: 10.1096/fj.10-157933. Epub 2010 Jun 28.

38.

Nanomedicine strategies for molecular targets with MRI and optical imaging.

Pan D, Caruthers SD, Chen J, Winter PM, SenPan A, Schmieder AH, Wickline SA, Lanza GM.

Future Med Chem. 2010 Mar;2(3):471-90. doi: 10.4155/fmc.10.5. Review.

39.

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.

Lanza GM, Winter PM, Caruthers SD, Hughes MS, Hu G, Schmieder AH, Wickline SA.

Angiogenesis. 2010 Jun;13(2):189-202. doi: 10.1007/s10456-010-9166-0. Epub 2010 Apr 22. Review.

40.

Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.

Caruthers SD, Cyrus T, Winter PM, Wickline SA, Lanza GM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 May-Jun;1(3):311-23. doi: 10.1002/wnan.9. Review.

PMID:
20049799
41.

MR molecular imaging of angiogenesis using targeted perfluorocarbon nanoparticles.

Caruthers SD, Winter PM, Wickline SA, Lanza GM, Keupp J.

Medicamundi. 2010;54(2):5-13. No abstract available.

42.

Conquering the dark side: colloidal iron oxide nanoparticles.

Senpan A, Caruthers SD, Rhee I, Mauro NA, Pan D, Hu G, Scott MJ, Fuhrhop RW, Gaffney PJ, Wickline SA, Lanza GM.

ACS Nano. 2009 Dec 22;3(12):3917-26. doi: 10.1021/nn900819y.

43.

Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids.

Pan D, Senpan A, Caruthers SD, Williams TA, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM.

Chem Commun (Camb). 2009 Jun 14;(22):3234-6. doi: 10.1039/b902875g. Epub 2009 Apr 22.

44.

Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.

Winter PM, Caruthers SD, Zhang H, Williams TA, Wickline SA, Lanza GM.

JACC Cardiovasc Imaging. 2008 Sep;1(5):624-34. doi: 10.1016/j.jcmg.2008.06.003.

45.

Nanomedicine: perspective and promises with ligand-directed molecular imaging.

Pan D, Lanza GM, Wickline SA, Caruthers SD.

Eur J Radiol. 2009 May;70(2):274-85. doi: 10.1016/j.ejrad.2009.01.042. Epub 2009 Mar 5. Review.

PMID:
19268515
46.

Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.

Kaneda MM, Caruthers S, Lanza GM, Wickline SA.

Ann Biomed Eng. 2009 Oct;37(10):1922-33. doi: 10.1007/s10439-009-9643-z. Epub 2009 Jan 30. Review.

47.

Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging.

Neubauer AM, Sim H, Winter PM, Caruthers SD, Williams TA, Robertson JD, Sept D, Lanza GM, Wickline SA.

Magn Reson Med. 2008 Dec;60(6):1353-61. doi: 10.1002/mrm.21795.

48.

Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging.

Neubauer AM, Myerson J, Caruthers SD, Hockett FD, Winter PM, Chen J, Gaffney PJ, Robertson JD, Lanza GM, Wickline SA.

Magn Reson Med. 2008 Nov;60(5):1066-72. doi: 10.1002/mrm.21750.

49.

High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model.

Lijowski M, Caruthers S, Hu G, Zhang H, Scott MJ, Williams T, Erpelding T, Schmieder AH, Kiefer G, Gulyas G, Athey PS, Gaffney PJ, Wickline SA, Lanza GM.

Invest Radiol. 2009 Jan;44(1):15-22. doi: 10.1097/RLI.0b013e31818935eb.

50.

Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.

Schmieder AH, Caruthers SD, Zhang H, Williams TA, Robertson JD, Wickline SA, Lanza GM.

FASEB J. 2008 Dec;22(12):4179-89. doi: 10.1096/fj.08-112060. Epub 2008 Aug 12.

Supplemental Content

Loading ...
Support Center